Jennifer A. Graf

771 total citations
15 papers, 607 citations indexed

About

Jennifer A. Graf is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Jennifer A. Graf has authored 15 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 4 papers in Pediatrics, Perinatology and Child Health and 2 papers in Infectious Diseases. Recurrent topics in Jennifer A. Graf's work include Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Jennifer A. Graf is often cited by papers focused on Pharmacogenetics and Drug Metabolism (5 papers), Pharmacological Effects and Toxicity Studies (4 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). Jennifer A. Graf collaborates with scholars based in United States. Jennifer A. Graf's co-authors include Polyxane Mertzanis, Jerold S. Harmatz, Richard I. Shader, Lisa L. von Moltke, David J. Greenblatt, Anna Liza B. Durol, Giorgio Cattoretti, Taha Merghoub, Alexander L. Dent and P P Pandolfi and has published in prestigious journals such as Nature Immunology, Molecular and Cellular Biology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Jennifer A. Graf

15 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer A. Graf United States	10	159	110	106	105	90	15	607
Shang‐Ying P. King United States	13	66 0.4×	99 0.9×	221 2.1×	178 1.7×	118 1.3×	21	928
Michael Steffens Germany	19	265 1.7×	139 1.3×	290 2.7×	110 1.0×	21 0.2×	60	1.1k
Mark G. Eller United States	17	80 0.5×	69 0.6×	208 2.0×	23 0.2×	64 0.7×	34	749
Benjamin Berger Switzerland	13	146 0.9×	78 0.7×	126 1.2×	30 0.3×	67 0.7×	23	518
Marcus C. Rosenhagen Germany	10	84 0.5×	122 1.1×	195 1.8×	35 0.3×	27 0.3×	15	586
F. Giménez France	15	147 0.9×	98 0.9×	87 0.8×	39 0.4×	16 0.2×	26	572
Gershwin T. Blyden United States	12	148 0.9×	98 0.9×	125 1.2×	164 1.6×	21 0.2×	30	691
Alex Hemeryck Belgium	12	204 1.3×	134 1.2×	220 2.1×	80 0.8×	19 0.2×	15	784
Elizabeth A. Lane United States	14	62 0.4×	74 0.7×	331 3.1×	32 0.3×	25 0.3×	36	808
Lisa A. Shipley United States	12	235 1.5×	138 1.3×	193 1.8×	57 0.5×	15 0.2×	22	581

Countries citing papers authored by Jennifer A. Graf

Since Specialization

Citations

This map shows the geographic impact of Jennifer A. Graf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer A. Graf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer A. Graf more than expected).

Fields of papers citing papers by Jennifer A. Graf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer A. Graf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer A. Graf. The network helps show where Jennifer A. Graf may publish in the future.

Co-authorship network of co-authors of Jennifer A. Graf

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer A. Graf. A scholar is included among the top collaborators of Jennifer A. Graf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer A. Graf. Jennifer A. Graf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Graf, Jennifer A., et al.. (2014). Success for People with Disabilities after Postsecondary Education. ScholarSpace (University of Hawaii at Manoa). 1(2). 1 indexed citations

2.

Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2003). Short‐Term Exposure to Low‐Dose Ritonavir Impairs Clearance and Enhances Adverse Effects of Trazodone. The Journal of Clinical Pharmacology. 43(4). 414–422. 48 indexed citations

3.

Venkatakrishnan, Karthik, Jürgen Schmider, Jerold S. Harmatz, et al.. (2001). Relative Contribution of CYP3A to Amitriptyline Clearance in Humans: In Vitro and In Vivo Studies. The Journal of Clinical Pharmacology. 41(10). 1043–1054. 49 indexed citations

4.

Graf, Jennifer A., et al.. (2001). Analysis of the Workforce Investment Act: Implications for Persons with Disabilities, Postsecondary Education and Life-long Learning Opportunities. Disability Studies Quarterly. 21(1). 2 indexed citations

5.

Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2000). Differential Impairment of Triazolam and Zolpidem Clearance by Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 129–136. 71 indexed citations

6.

Cattoretti, Giorgio, Jennifer A. Graf, Taha Merghoub, et al.. (2000). BCL-6 regulates chemokine gene transcription in macrophages. Nature Immunology. 1(3). 214–220. 143 indexed citations

7.

Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (2000). Differential Impairment of Triazolam and Zolpidem Clearance by Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 24(2). 129–136. 23 indexed citations

8.

Graf, Jennifer A., et al.. (1998). The Expression of Interleukin-1β Converting Enzyme (ICE) in Rat is Decreased Following Chronic Exposure to Morphine. Advances in experimental medicine and biology. 437. 51–58. 2 indexed citations

9.

Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (1998). Inhibition of triazolam clearance by macrolide antimicrobial agents: In vitro correlates and dynamic consequences*. Clinical Pharmacology & Therapeutics. 64(3). 278–285. 65 indexed citations

10.

Greenblatt, David J., Lisa L. von Moltke, Jerold S. Harmatz, et al.. (1998). Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole*. Clinical Pharmacology & Therapeutics. 64(6). 661–671. 62 indexed citations

11.

Greenblatt, David J., Jerold S. Harmatz, Lisa L. von Moltke, et al.. (1998). Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo*. Clinical Pharmacology & Therapeutics. 64(5). 553–561. 96 indexed citations

12.

Graf, Jennifer A., Jitesh A. Patel, & Sulie L. Chang. (1997). Chronic exposure to morphine, but not ethanol, attenuates the expression of interleukin-1β converting enzyme in rat spleen. Immunology Letters. 58(3). 153–157. 6 indexed citations

13.

Newman, Anna P., Jennifer A. Graf, Patrizia Mancini, et al.. (1992). SEC22 and SLY2 are identical.. Molecular and Cellular Biology. 12(8). 3663–3664. 24 indexed citations

14.

Ferro‐Novick, Susan, et al.. (1991). An analysis of Bet1, Bet2, and Bos1. Cell Biophysics. 19(1). 25–33. 5 indexed citations

15.

Graf, Jennifer A. & L Stockinger. (1966). Endoplasmatisches Retikulum und Reizleitung im Flimmerepithel. Cell and Tissue Research. 72(2). 184–192. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact